Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial.
O'Shea JC, Hafley GE, Greenberg S, Hasselblad V, Lorenz TJ, Kitt MM, Strony J, Tcheng JE; ESPRIT Investigators (Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy trial). O'Shea JC, et al. Among authors: lorenz tj. JAMA. 2001 May 16;285(19):2468-73. doi: 10.1001/jama.285.19.2468. JAMA. 2001. PMID: 11368699 Clinical Trial.
ESPRIT in context: pharmacology matters!
Tcheng JE, Strony J, Lorenz TJ, O'Shea JC. Tcheng JE, et al. Among authors: lorenz tj. Eur Heart J. 2001 Nov;22(21):1965-7. doi: 10.1053/euhj.2001.2682. Eur Heart J. 2001. PMID: 11603901 No abstract available.
Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study.
Fernandes LS, Tcheng JE, O'Shea JC, Weiner B, Lorenz TJ, Pacchiana C, Berdan LG, Maresh KJ, Joseph D, Madan M, Mann T, Kilaru R, Hochman JS, Kleiman NS; ESPRIT investigators. Fernandes LS, et al. Among authors: lorenz tj. J Am Coll Cardiol. 2002 Sep 18;40(6):1085-91. doi: 10.1016/s0735-1097(02)02120-4. J Am Coll Cardiol. 2002. PMID: 12354432 Free article.
Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.
Lopes RD, Williams JB, Mehta RH, Reyes EM, Hafley GE, Allen KB, Mack MJ, Peterson ED, Harrington RA, Gibson CM, Califf RM, Kouchoukos NT, Ferguson TB, Lorenz TJ, Alexander JH. Lopes RD, et al. Among authors: lorenz tj. Am Heart J. 2012 Sep;164(3):379-386.e1. doi: 10.1016/j.ahj.2012.05.019. Am Heart J. 2012. PMID: 22980305 Free PMC article. Clinical Trial.
33 results